Thanks to the efforts of chief executive officer Trevor Twose and Venture Investors, Mithridion survived the potentially game-ending development and is now moving forward, with 12 employees and a total of $8.4 million in financing since 2005. Twose did post-doctoral research at UW-Madison in the early 1970s and, 30 years later, returned as a biotech consultant and helped UW-Madison professor Fred Blattner start Scarab Genomics, a Madison company that makes drug development tools, before creating Mithridion.
Office of Strategic Communication